Literature DB >> 8604397

Stromal cells of the human prostate: initial isolation and characterization.

A Kassen1, D M Sutkowski, H Ahn, J A Sensibar, J M Kozlowski, C Lee.   

Abstract

The present study was conducted to isolate and to characterize stromal cells from the human prostate and to study the effects of androgen and different growth factors in this model system. Benign prostatic hyperplasia (BPH) tissue samples were obtained from transurethral resection of the prostate (TURP). Tissue specimens were mechanically and enzymatically dissociated by treatment with DNAse and collagenase. Epithelial cells were separated from stromal cells by discontinuous Percoll gradient centrifugation. The stromal cells obtained were cultured in phenol red-free RPMI-1640 supplemented with 10% fetal bovine serum. Immunocytochemical analysis revealed that the stromal cell cultures were composed of both smooth muscle cells and fibroblasts. The short and broad, smooth muscle cells wee identified by using an antibody directed against alpha-smooth muscle actin. The thin and elongated fibroblasts stained positively for prolyl 4-hydroxylase. Smooth muscle cells were the predominant cell type in the present investigation. Typical cultures contained up to 99% of cells staining positively for alpha-smooth muscle actin. The prostate smooth muscle cultures were treated with dihydrotestosterone (DHT), bovine pituitary extract (BPE), basic fibroblast growth factor (bFGF) and transforming growth factor-beta (TGF-beta). When cells were cultured in serum free RPMI-1640 supplemented with ITS+ (insulin, transferrin, and selenious acid) no significant (P > 0.05) mitogenic effect in medium supplemented with ITS+. In the presence of 10% charcoal-stripped fetal bovine serum (cFBS) DHT, at a concentration of 0.1 nM, was able to cause a slight but significant (P < 0.05) mitogenic effect on BPH smooth muscle cells growth. Basic FGF was able to stimulate BPH smooth muscle cells in a concentration-dependent fashion. The combination of DHT and 0.1 ng/ml bFGF was able to increase the proliferation of prostate smooth muscle cells above either agents alone. Addition of BPE to serum free RPMI-1640 caused a significant (P < 0.05) stimulation of cell proliferation in a concentration-dependent fashion. Addition to TGF-beta to serum or BPE containing RPMI-1640 caused a significant (P < 0.05) inhibition to cell proliferation in a concentration-dependent fashion. TGF-beta was cytostatic to the benign prostatic smooth muscle cells only in the presence of media containing growth stimulating factors found in charcoal-stripped serum or in bovine pituitary extract. These results demonstrated that stromal fraction isolated from BPH specimens was composed of both fibroblasts and smooth muscle cells. These cells could be cultured and were able to respond to various growth stimulatory and inhibitory agents.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8604397     DOI: 10.1002/(SICI)1097-0045(199602)28:2<89::AID-PROS3>3.0.CO;2-I

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  22 in total

1.  Modulation of prostate cancer cell gene expression by cell-to-cell contact with bone marrow stromal cells or osteoblasts.

Authors:  Shuming Zhang; Jun Wang; Mehmet A Bilen; Sue-Hwa Lin; Samuel I Stupp; Robert L Satcher
Journal:  Clin Exp Metastasis       Date:  2009-09-29       Impact factor: 5.150

2.  Studying primary tumor-associated fibroblast involvement in cancer metastasis in mice.

Authors:  Annique M M J Duyverman; Ernst J A Steller; Dai Fukumura; Rakesh K Jain; Dan G Duda
Journal:  Nat Protoc       Date:  2012-03-22       Impact factor: 13.491

3.  Cell-cell interaction in prostate gene regulation and cytodifferentiation.

Authors:  A Y Liu; L D True; L LaTray; P S Nelson; W J Ellis; R L Vessella; P H Lange; L Hood; G van den Engh
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

4.  Inflammatory cytokine expression is correlated with the level of human immunodeficiency virus (HIV) transcripts in HIV-infected placental trophoblastic cells.

Authors:  B N Lee; N Ordonez; E J Popek; J G Lu; A Helfgott; N Eriksen; H Hammill; C Kozinetz; M Doyle; M Kline; C Langston; W T Shearer; J M Reuben
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

5.  Genomic analysis of benign prostatic hyperplasia implicates cellular re-landscaping in disease pathogenesis.

Authors:  Lance W Middleton; Zhewei Shen; Sushama Varma; Anna S Pollack; Xue Gong; Shirley Zhu; Chunfang Zhu; Joseph W Foley; Sujay Vennam; Robert T Sweeney; Karen Tu; Jewison Biscocho; Okyaz Eminaga; Rosalie Nolley; Robert Tibshirani; James D Brooks; Robert B West; Jonathan R Pollack
Journal:  JCI Insight       Date:  2019-05-16

6.  Differential Inductive Signaling of CD90 Prostate Cancer-Associated Fibroblasts Compared to Normal Tissue Stromal Mesenchyme Cells.

Authors:  Laura E Pascal; Junkui Ai; Ricardo Z N Vêncio; Eneida F Vêncio; Yong Zhou; Laura S Page; Lawrence D True; Zhou Wang; Alvin Y Liu
Journal:  Cancer Microenviron       Date:  2011-01-07

7.  Gene expression down-regulation in CD90+ prostate tumor-associated stromal cells involves potential organ-specific genes.

Authors:  Laura E Pascal; Young Ah Goo; Ricardo Zn Vêncio; Laura S Page; Amber A Chambers; Emily S Liebeskind; Thomas K Takayama; Lawrence D True; Alvin Y Liu
Journal:  BMC Cancer       Date:  2009-09-08       Impact factor: 4.430

8.  The effects of aging on the molecular and cellular composition of the prostate microenvironment.

Authors:  Daniella Bianchi-Frias; Funda Vakar-Lopez; Ilsa M Coleman; Stephen R Plymate; May J Reed; Peter S Nelson
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

9.  Distinct function of estrogen receptor α in smooth muscle and fibroblast cells in prostate development.

Authors:  Spencer Vitkus; Chiuan-Ren Yeh; Hsiu-Hsia Lin; Iawen Hsu; Jiangzhou Yu; Ming Chen; Shuyuan Yeh
Journal:  Mol Endocrinol       Date:  2012-11-30

10.  Dual regulation of proliferation and growth arrest in prostatic stromal cells by transforming growth factor-beta1.

Authors:  Wei Zhou; Irwin Park; Michael Pins; James M Kozlowski; Borko Jovanovic; Ju Zhang; Chung Lee; Kenneth Ilio
Journal:  Endocrinology       Date:  2003-07-24       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.